Logo image of ACWN.DE

AS CREATION TAPETEN AG (ACWN.DE) Stock Fundamental Analysis

FRA:ACWN - Deutsche Boerse Ag - DE000A1TNNN5 - Common Stock - Currency: EUR

5.7  +0.1 (+1.79%)

Fundamental Rating

3

Overall ACWN gets a fundamental rating of 3 out of 10. We evaluated ACWN against 33 industry peers in the Household Durables industry. The financial health of ACWN is average, but there are quite some concerns on its profitability. ACWN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ACWN had negative earnings in the past year.
ACWN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ACWN reported negative net income in multiple years.
Each year in the past 5 years ACWN had a positive operating cash flow.
ACWN.DE Yearly Net Income VS EBIT VS OCF VS FCFACWN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

1.2 Ratios

ACWN has a Return On Assets of -5.74%. This is amonst the worse of the industry: ACWN underperforms 87.88% of its industry peers.
The Return On Equity of ACWN (-9.14%) is worse than 84.85% of its industry peers.
Industry RankSector Rank
ROA -5.74%
ROE -9.14%
ROIC N/A
ROA(3y)-3.91%
ROA(5y)-1.51%
ROE(3y)-6.04%
ROE(5y)-2.3%
ROIC(3y)N/A
ROIC(5y)N/A
ACWN.DE Yearly ROA, ROE, ROICACWN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

ACWN's Gross Margin of 50.68% is fine compared to the rest of the industry. ACWN outperforms 69.70% of its industry peers.
ACWN's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ACWN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.05%
ACWN.DE Yearly Profit, Operating, Gross MarginsACWN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

6

2. Health

2.1 Basic Checks

ACWN does not have a ROIC to compare to the WACC, probably because it is not profitable.
ACWN has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ACWN has about the same amount of shares outstanding.
The debt/assets ratio for ACWN has been reduced compared to a year ago.
ACWN.DE Yearly Shares OutstandingACWN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
ACWN.DE Yearly Total Debt VS Total AssetsACWN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

ACWN has an Altman-Z score of 2.19. This is not the best score and indicates that ACWN is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ACWN (2.19) is better than 60.61% of its industry peers.
ACWN has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.10, ACWN belongs to the best of the industry, outperforming 87.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 2.19
ROIC/WACCN/A
WACC5.45%
ACWN.DE Yearly LT Debt VS Equity VS FCFACWN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 3.32 indicates that ACWN has no problem at all paying its short term obligations.
ACWN has a Current ratio of 3.32. This is amongst the best in the industry. ACWN outperforms 84.85% of its industry peers.
A Quick Ratio of 1.82 indicates that ACWN should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.82, ACWN belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.32
Quick Ratio 1.82
ACWN.DE Yearly Current Assets VS Current LiabilitesACWN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for ACWN have decreased strongly by -324.38% in the last year.
The Revenue has decreased by -8.15% in the past year.
The Revenue has been decreasing by -4.62% on average over the past years.
EPS 1Y (TTM)-324.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-148.42%
Revenue 1Y (TTM)-8.15%
Revenue growth 3Y-8.56%
Revenue growth 5Y-4.62%
Sales Q2Q%-8.77%

3.2 Future

The Earnings Per Share is expected to grow by 35.10% on average over the next years. This is a very strong growth
ACWN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.26% yearly.
EPS Next Y114.96%
EPS Next 2Y55.66%
EPS Next 3Y35.1%
EPS Next 5YN/A
Revenue Next Year2.92%
Revenue Next 2Y3.46%
Revenue Next 3Y3.47%
Revenue Next 5Y3.26%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ACWN.DE Yearly Revenue VS EstimatesACWN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
ACWN.DE Yearly EPS VS EstimatesACWN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ACWN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 15.97, the valuation of ACWN can be described as correct.
Based on the Price/Forward Earnings ratio, ACWN is valued a bit more expensive than 63.64% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.42. ACWN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 15.97
ACWN.DE Price Earnings VS Forward Price EarningsACWN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACWN.DE Per share dataACWN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ACWN's earnings are expected to grow with 35.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.66%
EPS Next 3Y35.1%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACWN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AS CREATION TAPETEN AG

FRA:ACWN (5/8/2025, 7:00:00 PM)

5.7

+0.1 (+1.79%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)05-14 2025-05-14
Inst Owners10.78%
Inst Owner ChangeN/A
Ins Owners59.38%
Ins Owner ChangeN/A
Market Cap15.73M
Analysts85.71
Price Target14.28 (150.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.97
P/S 0.14
P/FCF N/A
P/OCF 25.29
P/B 0.24
P/tB 0.26
EV/EBITDA N/A
EPS(TTM)-2.18
EYN/A
EPS(NY)0.36
Fwd EY6.26%
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)0.23
OCFY3.95%
SpS40.34
BVpS23.87
TBVpS21.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.74%
ROE -9.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.68%
FCFM N/A
ROA(3y)-3.91%
ROA(5y)-1.51%
ROE(3y)-6.04%
ROE(5y)-2.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.05%
F-Score4
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 28.83%
Cap/Sales 1.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.32
Quick Ratio 1.82
Altman-Z 2.19
F-Score4
WACC5.45%
ROIC/WACCN/A
Cap/Depr(3y)47.95%
Cap/Depr(5y)59.64%
Cap/Sales(3y)2.26%
Cap/Sales(5y)2.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-324.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-148.42%
EPS Next Y114.96%
EPS Next 2Y55.66%
EPS Next 3Y35.1%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.15%
Revenue growth 3Y-8.56%
Revenue growth 5Y-4.62%
Sales Q2Q%-8.77%
Revenue Next Year2.92%
Revenue Next 2Y3.46%
Revenue Next 3Y3.47%
Revenue Next 5Y3.26%
EBIT growth 1Y-249.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year180.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-419.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.56%
OCF growth 3Y-57.28%
OCF growth 5YN/A